Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 83.87%4.64B | -83.24%458M | 281.58%1.31B | -9.18%7.16B | -66.86%1.56B | -23.91%2.52B | 280.11%2.73B | 139.63%342M | 9.97%7.88B | 1.79%4.71B |
| Net income from continuing operations | 30.68%2.01B | 885.71%1.73B | -6.77%1.63B | 48.31%5.01B | 5.91%1.56B | 264.52%1.54B | -87.12%175M | 17.69%1.74B | -36.55%3.38B | 0.34%1.47B |
| Operating gains losses | 1.84%-320M | 4.88%-312M | 56.97%-324M | -11.96%-1.74B | 14.58%-334M | 15.54%-326M | 15.90%-328M | -94.07%-753M | -10.05%-1.56B | -11.40%-391M |
| Depreciation and amortization | -0.27%1.09B | 0.37%1.08B | -0.66%1.05B | 3.63%4.36B | 7.55%1.14B | 1.86%1.09B | 2.68%1.07B | 2.42%1.06B | 2.51%4.21B | 1.05%1.06B |
| Remuneration paid in stock | 38.51%241M | 44.57%253M | 43.30%278M | 2.82%437M | -200.00%-106M | 62.62%174M | 56.25%175M | 94.00%194M | 1.19%425M | 3.92%106M |
| Deferred tax | 256.91%477M | -81.94%54M | 158.77%67M | 88.31%-47M | -77.91%72M | -985.71%-304M | 180.59%299M | 65.35%-114M | 75.83%-402M | 1,711.11%326M |
| Other non cashItems | -385.29%-97M | -74.19%-162M | -51.55%-147M | -29.45%218M | 315.56%374M | -5.56%34M | -137.05%-93M | -42.65%-97M | 332.33%309M | -35.25%90M |
| Change In working capital | 292.72%1.24B | -251.85%-2.18B | 26.27%-1.25B | -171.62%-1.09B | -155.86%-1.14B | -90.83%316M | 211.43%1.43B | 37.24%-1.69B | 190.23%1.52B | -7.08%2.05B |
| -Change in receivables | -98.61%-1.29B | -286.69%-1.25B | -97.07%-1.08B | -1.21%-2.59B | -122.41%-1.07B | -1,320.75%-647M | -1,141.94%-323M | 74.68%-547M | -1,360.10%-2.56B | -154.71%-482M |
| -Change in inventory | 152.91%182M | 46.29%-384M | -25.85%-813M | -33.51%-1.47B | -29.14%231M | -218.52%-344M | -18.77%-715M | 10.28%-646M | 29.90%-1.1B | 331.21%326M |
| -Change in payables and accrued expense | 106.75%2.24B | -136.77%-538M | 282.11%397M | -62.45%1.51B | -237.88%-819M | -69.70%1.08B | 328.95%1.46B | -144.49%-218M | 93.54%4.02B | -23.55%594M |
| -Change in other current assets | -91.50%-879M | -94.34%25M | 44.44%-125M | 65.37%-402M | 43.46%-160M | -88.11%-459M | 509.26%442M | 57.22%-225M | -13.05%-1.16B | 36.12%-283M |
| -Change in other working capital | 44.15%986M | -105.30%-30M | 790.74%373M | -19.38%1.87B | -64.29%676M | 293.10%684M | 1,668.75%566M | -124.22%-54M | 174.47%2.32B | 67.52%1.89B |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 83.87%4.64B | -83.24%458M | 281.58%1.31B | -9.18%7.16B | -66.86%1.56B | -23.91%2.52B | 280.11%2.73B | 139.63%342M | 9.97%7.88B | 1.79%4.71B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 165.87%471M | 30.56%-509M | -197.84%-678M | 49.52%-1.53B | 20.35%-779M | 16.76%-715M | -17.66%-733M | 219.69%693M | -7.42%-3.04B | -4.26%-978M |
| Capital expenditure reported | -11.23%-614M | 1.30%-530M | -9.85%-513M | -8.70%-2.63B | -32.80%-1.07B | 2.13%-552M | -2.09%-537M | 10.19%-467M | -5.55%-2.42B | 5.85%-805M |
| Net intangibles purchas and sale | 6.20%-121M | 21.29%-122M | 36.20%-104M | 18.64%-611M | 23.72%-164M | 41.89%-129M | 3.13%-155M | -5.84%-163M | -54.21%-751M | -27.22%-215M |
| Net business purchase and sale | --1.19B | --0 | --0 | 29,816.67%1.8B | --512M | --0 | --0 | --1.28B | -78.57%6M | --0 |
| Net investment purchase and sale | 31.25%42M | 785.71%192M | -4,600.00%-47M | -244.95%-158M | -226.77%-161M | 150.79%32M | -148.28%-28M | 92.31%-1M | 161.93%109M | 118.97%127M |
| Net other investing changes | 63.64%-24M | -276.92%-49M | -134.15%-14M | 441.67%65M | 221.18%103M | -312.50%-66M | -360.00%-13M | -62.04%41M | -87.23%12M | -403.57%-85M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 165.87%471M | 30.56%-509M | -197.84%-678M | 49.52%-1.53B | 20.35%-779M | 16.76%-715M | -17.66%-733M | 219.69%693M | -7.42%-3.04B | -4.26%-978M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -238.77%-3.92B | 77.71%-353M | 47.38%-1.06B | -46.17%-6.62B | 28.65%-1.87B | 51.28%-1.16B | -152.23%-1.58B | -283.12%-2.01B | 22.73%-4.53B | 8.11%-2.62B |
| Net issuance payments of debt | -24,433.33%-2.94B | 193.72%642M | 101.95%19M | -121.04%-2.5B | -109.76%-835M | 84.42%-12M | -180.49%-685M | -137.88%-972M | 2,343.33%11.9B | 647.25%8.56B |
| Net common stock issuance | --0 | --0 | 10.71%-50M | 96.55%-444M | 99.51%-50M | 79.43%-294M | 92.62%-44M | 90.04%-56M | -359.15%-12.87B | -2,420.34%-10.28B |
| Cash dividends paid | -10.57%-910M | -10.57%-910M | -9.23%-840M | 0.68%-3.22B | -4.56%-802M | 1.79%-823M | 2.49%-823M | 2.66%-769M | -3.55%-3.24B | 3.03%-767M |
| Net other financing activities | -137.93%-69M | -165.63%-85M | 11.90%-185M | -42.59%-452M | -42.52%-181M | 12.12%-29M | 17.95%-32M | -77.97%-210M | 23.61%-317M | -47.67%-127M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -238.77%-3.92B | 77.71%-353M | 47.38%-1.06B | -46.17%-6.62B | 28.65%-1.87B | 51.28%-1.16B | -152.23%-1.58B | -283.12%-2.01B | 22.73%-4.53B | 8.11%-2.62B |
| Net cash flow | ||||||||||
| Beginning cash position | -20.45%4.78B | -8.03%5.16B | -15.39%5.61B | 5.33%6.63B | 22.47%6.68B | 11.50%6.01B | -4.85%5.61B | 5.33%6.63B | -19.89%6.29B | 1.39%5.46B |
| Current changes in cash | 82.62%1.19B | -197.12%-404M | 55.86%-429M | -412.93%-992M | -197.40%-1.09B | 712.50%650M | 178.20%416M | -180.92%-972M | 120.86%317M | 32.58%1.12B |
| Effect of exchange rate changes | -143.48%-10M | 1,050.00%38M | 300.00%16M | -255.56%-28M | -378.57%-39M | 253.33%23M | -122.22%-4M | -900.00%-8M | 142.86%18M | -6.67%14M |
| Cash adjustments other than cash changes | 450.00%7M | -12.50%-9M | 7.69%-36M | 28.21%-28M | 950.00%21M | ---2M | -166.67%-8M | 26.42%-39M | 45.07%-39M | 111.76%2M |
| End cash Position | -10.72%5.97B | -20.45%4.78B | -8.03%5.16B | -15.32%5.58B | -15.32%5.58B | 22.47%6.68B | 11.50%6.01B | -4.85%5.61B | 5.90%6.59B | 5.90%6.59B |
| Free cash from | 111.94%3.9B | -109.51%-194M | 338.89%688M | -16.83%3.92B | -91.11%328M | -27.19%1.84B | 6,084.85%2.04B | 81.26%-288M | 7.38%4.72B | 2.41%3.69B |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.